Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 0.52 MYR
Change Today +0.015 / 2.97%
Volume 11.4K
MGRC On Other Exchanges
Symbol
Exchange
Kuala Lumpur
As of 3:42 AM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

malaysian genomics resource (MGRC) Snapshot

Open
0.51
Previous Close
0.51
Day High
0.52
Day Low
0.51
52 Week High
03/19/15 - 0.64
52 Week Low
02/10/15 - 0.36
Market Cap
48.9M
Average Volume 10 Days
10.6K
EPS TTM
0.04
Shares Outstanding
94.1M
EX-Date
--
P/E TM
14.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for MALAYSIAN GENOMICS RESOURCE (MGRC)

Related News

No related news articles were found.

malaysian genomics resource (MGRC) Related Businessweek News

No Related Businessweek News Found

malaysian genomics resource (MGRC) Details

Malaysian Genomics Resource Centre Berhad, an investment holding company, provides genome sequencing, bioinformatics analysis, and genetic screening services, as well as online access to genomic data and bioinformatics applications. Its services include sequencing and analysis of various human, animal, plant, and microbial genomes for customers worldwide. The company offers high-throughput sequencing services, including whole genome and transcriptome sequencing, and metagenomics and metatranscriptomics services. It also provides contract genomics services, which comprise reads quality analysis, whole genome assembly, variation analysis of genomes, gene annotation, and exome and transcriptome analysis, as well as other analytical pipelines for processing ChIP-Seq data, annotating and analysing microRNAs, and analysing mutations; trait analysis services to screen multiple samples of previously identified genetic markers within plant and animal genomes; and Trio sequencing services, which provide a detailed view of an individual’s DNA. In addition, the company offers genetic screening services, such as Dtect, a range of test panels that are designed to screen for genetic markers in an individual’s DNA; Cyto Dtect for screening various genetic loci across the genome; and Gene Dtect that screens patterns of genetic variation within various human genes in the protein coding space. Further, it provides online tools for searching, annotation and mapping, and advanced analysis; and operates a biocomputational center for genomics. Malaysian Genomics Resource Centre Berhad serves hospitals, research organizations, academic institutions, government ministries, and corporations. The company was founded in 2004 and is based in Kuala Lumpur, Malaysia. Malaysian Genomics Resource Centre Berhad is a subsidiary of Synamatix Sdn Bhd.

Founded in 2004

malaysian genomics resource (MGRC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

malaysian genomics resource (MGRC) Key Developments

Malaysian Genomics Resource Centre Berhad to Report Q3, 2015 Results on May 25, 2015

Malaysian Genomics Resource Centre Berhad announced that they will report Q3, 2015 results on May 25, 2015

Malaysian Genomics Resource Centre Berhad Announces Unaudited Group Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015

Malaysian Genomics Resource Centre Berhad announced unaudited group earnings results for the third quarter and nine months ended March 31, 2015. For the quarter, the company reported revenue of MYR 4,293,000 against MYR 423,000 a year ago. Profit from operations was MYR 1,212,000 against loss from operations of MYR 2,084,000 a year ago. Profit before tax was MYR 1,298,000 against loss before tax of MYR 1,956,000 a year ago. Profit attributable to the owners of the parent was MYR 1,296,000 or 1.38 sen per basic share against loss attributable to the owners of the parent of MYR 1,961,000 or 2.08 sen per basic share a year ago. For the nine months, the company reported revenue of MYR 10,543,000 against MYR 2,411,000 a year ago. Profit from operations was MYR 2,576,000 against loss from operations of MYR 5,161,000 a year ago. Profit before tax was MYR 3,151,000 against loss before tax of MYR 4,516,000 a year ago. Profit attributable to the owners of the parent was MYR 3,146,000 or 3.34 sen per basic share against loss attributable to the owners of the parent of MYR 4,536,000 or 4.82 sen per basic share a year ago. Net cash generated from operating activities was MYR 673,000 against net cash used in operating activities of MYR 3,074,000 a year ago. Purchase of plant and equipment was MYR 190,000 against MYR 42,000 a year ago.

Malaysian Genomics Resource Centre Berhad Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2014

Malaysian Genomics Resource Centre Berhad reported unaudited consolidated earnings results for the second quarter and six months ended December 31, 2014. For the quarter, the company reported revenue of MYR 3,693,000 against MYR 1,383,000 a year ago. Profit from operations was MYR 1,130,000 against loss from operations of MYR 1,152,000 a year ago. Profit before tax was MYR 1,355,000 against loss before tax of MYR 832,000 a year ago. The profit before tax achieved was mainly due to higher revenue. Profit attributable to owners of the parent was MYR 1,353,000 or 1.44 sen per basic share against loss attributable to owners of the parent of MYR 839,000 or 0.89 sen per basic share a year ago. For the six months, the company reported revenue of MYR 6,250,000 against MYR 1,988,000 a year ago. Profit from operations was MYR 1,364,000 against loss from operations of MYR 3,077,000 a year ago. Profit before tax was MYR 1,853,000 against loss before tax of MYR 2,560,000 a year ago. Profit attributable to owners of the parent was MYR 1,850,000 or 1.97 sen per basic share against loss attributable to owners of the parent of MYR 2,575,000 or 2.74 sen per basic share a year ago. Net cash generated from operating activities was MYR 2,507,000 against net cash used in operating activities of MYR 2,206,000 a year ago. Purchase of plant and equipment was MYR 131,000 against MYR 29,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MGRC:MK 0.52 MYR +0.015

MGRC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MGRC.
View Industry Companies
 

Industry Analysis

MGRC

Industry Average

Valuation MGRC Industry Range
Price/Earnings 100.0x
Price/Sales 5.2x
Price/Book 2.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MALAYSIAN GENOMICS RESOURCE, please visit www.mgrc.com.my. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.